Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Safety, Tolerability, and Immunogenicity of V110 or V114 Co-administered With a Booster Dose of mRNA-1273 in Healthy Adults (V110-911)

ClinicalTrials.gov ID: NCT05158140

Public ClinicalTrials.gov record NCT05158140. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 10:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Concomitant Administration of Either 23-Valent Pneumococcal Polysaccharide Vaccine or 15-Valent Pneumococcal Conjugate Vaccine With a Booster Dose of SARS-CoV-2 mRNA Vaccine in Healthy Adults 50 Years of Age or Older.

Study identification

NCT ID
NCT05158140
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
850 participants

Conditions and interventions

Interventions

  • V110 Biological
  • V114 Biological
  • mRNA-1273 Biological
  • Placebo for V110 Biological
  • Placebo for V114 Biological

Biological

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 11, 2022
Primary completion
Feb 20, 2023
Completion
Feb 20, 2023
Last update posted
Jul 17, 2025

2022 – 2023

United States locations

U.S. sites
42
U.S. states
19
U.S. cities
41
Facility City State ZIP Site status
Carbon Health ( Site 0045) North Hollywood California 91606
Valley Clinical Trials Inc. ( Site 0002) Northridge California 91325
Center for Clinical Trials, LLC ( Site 0022) Paramount California 90723
Artemis Institute for Clinical Research ( Site 0024) San Diego California 92103
California Research Foundation ( Site 0004) San Diego California 92123
Millennium Clinical Trials ( Site 0027) Simi Valley California 93065
Diablo Clinical Research, Inc ( Site 0043) Walnut Creek California 94598
Alliance for Multispecialty Research, LLC ( Site 0036) Coral Gables Florida 33134
Indago Research and Health Center Inc ( Site 0006) Hialeah Florida 33012
Optimal Research LLC ( Site 0019) Melbourne Florida 32934
Advanced Medical Research, LLC ( Site 0030) Miami Florida 33174
Lakes Research LLC ( Site 0012) Miami Lakes Florida 33014
Atlanta Center For Medical Research ( Site 0053) Atlanta Georgia 30331
Optimal Research ( Site 0054) Peoria Illinois 61614
Alliance for Multispecialty Research, LLC ( Site 0018) Newton Kansas 67114
AMR Lexington ( Site 0055) Lexington Kentucky 40509
Centennial Medical Group ( Site 0016) Elkridge Maryland 21075
Community Clinical Research Center ( Site 0032) Marlborough Massachusetts 01752
Alliance for Multispecialty Research, LLC ( Site 0011) Kansas City Missouri 64114
Wake Research Clinical Research Center of Nevada, LLC ( Site 0021) Las Vegas Nevada 89106
AXCES Research Group ( Site 0017) Santa Fe New Mexico 87505
Certified Research Associates ( Site 0042) Cortland New York 13045
Corning Center for Clinical Research ( Site 0052) Horseheads New York 14845
Rochester Clinical Research, Inc. ( Site 0010) Rochester New York 14609
Accellacare - Winston-Salem ( Site 0049) Winston-Salem North Carolina 27103
Velocity Clinical Research- Cleveland ( Site 0023) Cleveland Ohio 44122
Velocity Clinical Research-Providence ( Site 0015) East Greenwich Rhode Island 02818
Coastal Carolina Research Center ( Site 0044) North Charleston South Carolina 29405
Benchmark Research ( Site 0007) Austin Texas 78705
South Texas Clinical Research ( Site 0033) Corpus Christi Texas 78413
Benchmark Research ( Site 0039) Fort Worth Texas 76135
University of Texas Medical Branch at Galveston ( Site 0037) Galveston Texas 77555-1115
Texas Center For Drug Development ( Site 0013) Houston Texas 77081
Wellness Clinical Research Associates ( Site 0051) McKinney Texas 75071
Diagnostics Research Group ( Site 0001) San Antonio Texas 78229
DM Clinical Research ( Site 0025) Tomball Texas 77375
Crossroads Clinical Research LLC ( Site 0020) Victoria Texas 77901
Velocity Clinical Research, Salt Lake City ( Site 0035) West Jordan Utah 84088
Charlottesville Medical Research Center, LLC ( Site 0008) Charlottesville Virginia 22911
Health Research of Hampton Roads, Inc. ( Site 0014) Newport News Virginia 23606
Alliance for Multispecialty Research LLC (AMR - Norfolk) ( Site 0057) Norfolk Virginia 23502
Clinical Research Partners, LLC. ( Site 0005) Richmond Virginia 23226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05158140, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 17, 2025 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05158140 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →